首頁 > 市場調查報告書 > 製藥

OTC 非處方藥

市場調查報告書

商品編碼

1370972

消費者保健市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按類型（非處方藥、膳食補充劑）、按應用（零售、線上、醫院）、按地區和競爭細分

Consumer Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (OTC Pharmaceuticals, Dietary Supplements), By Application (Retail, Online, Hospitals), By Region and Competition

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球消費者醫療保健市場價值為 3,447 億美元，預計在整個預測期內將出現強勁成長，年複合成長率(CAGR)為 8.14%，預計到2028年將達到 5,519.1 億美元。消費者醫療保健包括與健康、口腔健康、營養和皮膚健康相關的一系列產品。該部門主要由非處方藥 (OTC) 組成，包括藥品、維生素和礦物質補充劑，無需處方即可直接銷售給消費者。非處方藥的例子包括牙膏、漱口水、某些眼藥水、除疣劑、含抗生素的急救霜和去屑洗髮精。這些產品受到各國監管機構的監管，以確保在沒有醫生監督的情況下使用時的安全性和可靠性。

主要市場促進因素

提高對生活方式疾病的認知

市場概況
預測期	2024-2028
2022年市場規模	3,447億美元
2028年市場規模	5519.1億美元
2023-2028年年複合成長率	8.14%
成長最快的細分市場	非處方藥
最大的市場	北美洲

對生活方式疾病的認知不斷提高是市場成長的重要動力。都市化和消費主義導致飲食習慣和生活方式的轉變，導致人工和合成食品的消費增加。因此，由於久坐的生活方式和飲食不均衡，心臟病、肥胖、糖尿病和動脈粥狀硬化等生活方式疾病的盛行率上升。消費者越來越意識到這些影響，導致人們開始購買膳食補充品、運動營養品和體重管理產品。這一趨勢推動消費者保健市場的成長，新的參與者進入市場，在過敏緩解、消化健康、女性護理、疼痛緩解和膳食補充劑等領域提供增值產品。

遠距醫療和遠距醫療的快速採用

COVID-19 大流行加速了遠距醫療和遠距醫療在全球的採用，對消費者醫療保健市場產生了重大影響。患者已轉向虛擬醫療保健解決方案，為消費者醫療保健產品分銷商創造了根據患者需求客製化產品的機會。這一趨勢促進消費者保健產品的創新並推動市場成長。

以患者為中心的治療的需求不斷增加

以患者為中心的護理趨勢使個人能夠在管理自己的健康方面發揮積極作用，這推動對個人化醫療保健解決方案的需求。患者尋求適合其健康目標和狀況的產品和服務，導致對健康和保健產品的需求激增，包括維生素、補充劑、健身器材、健康食品和替代療法。這一趨勢與數位健康工具和穿戴式裝置的使用相一致，這些工具和穿戴式裝置使患者能夠即時監控自己的健康指標。

老年人口增加

不斷增加的老年人口日益增加對消費者保健產品和服務的需求。老年人通常需要與健康相關的產品和服務來滿足他們獨特的健康挑戰。老年人經常患有慢性健康問題，導致對藥物、監測設備和生活方式管理工具等消費者保健產品的需求。老年人對維生素、補充劑和健康服務等預防保健產品的需求也在上升。

主要市場挑戰

假藥的盛行

假藥的存在給消費者醫療保健產業帶來了重大挑戰。假冒藥物經常扭曲其來源、合法性或功效，危害公眾健康。這些產品可能含有不足或不含活性成分，導致治療失敗或不良反應。打擊假藥對於確保消費者安全和市場成長非常重要。

低度開發地區的挑戰

在低度開發地區，擴大消費者醫療保健市場面臨挑戰，這些地區的醫療保健基礎設施不足、經濟疲軟和意識有限，阻礙了產品和服務的分銷。缺乏數位解決方案以及對新產品的懷疑進一步阻礙了這些領域的市場成長。

主要市場趨勢

加速線上資源的使用

消費者醫療保健行業線上資源的使用增加是一個突出趨勢。線上平台提供健康相關訊息，支持使用非處方藥進行自我治療。消費者保健公司利用線上平台進行行銷和銷售，擴大電子商務管道，並滿足對健康相關內容和產品不斷成長的需求。

自我治療的傾向不斷上升

自我藥療的趨勢推動消費者保健產品的需求。消費者積極利用非處方藥、補充劑和健康相關應用程式解決輕微的健康問題。這一趨勢影響產品開發並增加對一系列醫療保健解決方案的需求。

細分市場洞察

類型細分

市場分為非處方藥品和膳食補充劑。非處方藥因其治療常見疾病的安全性和有效性而在市場上佔據主導地位。然而，隨著消費者尋求個人化的健康解決方案，包括維生素和礦物質在內的膳食補充劑預計將經歷最高的成長率。

最終用戶細分

零售是最大的細分，包括零售藥局和有組織/無組織的零售店。由於網路普及率的提高和人們對網路購物好處的認知不斷提高，網路零售預計將快速成長。

區域洞察

在主要製藥公司和高效分銷管道的推動下，北美引領市場。歐洲緊隨其後，對天然成分和預防性醫療保健的需求不斷成長。亞太地區也在經歷成長，特別是由於意識和網路普及率的提高。

Global Consumer Healthcare Market was valued at USD 344.70 billion, and it is anticipated to experience strong growth throughout the forecast period, with a Compound Annual Growth Rate (CAGR) of 8.14% and expected to reach USD 551.91 Billion through 2028. Consumer healthcare encompasses a range of products related to wellness, oral health, nutrition, and skin health. This sector primarily consists of over-the-counter (OTC) drugs, including medicines, vitamins, and mineral supplements that are sold directly to consumers without a prescription. Examples of OTC drugs include toothpaste, mouthwashes, certain eye drops, wart removers, first aid creams with antibiotics, and dandruff shampoos. These products are regulated by various countries' regulatory agencies to ensure their safety and reliability when used without physician supervision.

Key Market Drivers

Increasing Awareness of Lifestyle Diseases

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 344.70 Billion
Market Size 2028	USD 551.91 Billion
CAGR 2023-2028	8.14%
Fastest Growing Segment	OTC Pharmaceuticals
Largest Market	North America

The rising awareness of lifestyle diseases is a significant driver of market growth. Urbanization and consumerism have led to shifts in dietary habits and lifestyles, resulting in an increase in the consumption of artificial and synthetic food products. Consequently, the prevalence of lifestyle diseases such as heart disease, obesity, diabetes, and atherosclerosis has risen due to sedentary lifestyles and imbalanced diets. Consumers are becoming more aware of these implications, leading to an uptake in dietary supplements, sports nutrition, and weight management products. This trend is driving the consumer healthcare market's growth, with new players entering the market to offer value-added products in segments such as allergy relief, digestive health, feminine care, pain relief, and dietary supplements.

Rapid Adoption of Telehealth and Telemedicine

The global adoption of telehealth and telemedicine, accelerated by the COVID-19 pandemic, has significantly impacted the consumer healthcare market. Patients have turned to virtual healthcare solutions, creating opportunities for consumer healthcare product distributors to tailor their offerings to patients' needs. This trend is fostering innovation in consumer healthcare products and driving market growth.

Increasing Demand for Patient-Centric Treatments

The trend toward patient-centric care, which empowers individuals to take an active role in managing their health, is driving the demand for personalized healthcare solutions. Patients are seeking products and services tailored to their health goals and conditions, leading to a surge in demand for health and wellness products, including vitamins, supplements, fitness equipment, healthy foods, and alternative therapies. This trend aligns with the use of digital health tools and wearables that allow patients to monitor their health metrics in real time.

Rising Geriatric Population

The increasing geriatric population is boosting the demand for consumer healthcare products and services. Older adults often require health-related products and services that cater to their unique health challenges. Geriatric individuals frequently have chronic health conditions, leading to a demand for consumer healthcare products like medications, monitoring devices, and lifestyle management tools. The demand for preventive healthcare products such as vitamins, supplements, and wellness services is also rising among older adults.

Key Market Challenges

Prevalence of Counterfeit Pharmaceuticals

The presence of counterfeit pharmaceuticals poses a significant challenge to the consumer healthcare industry. Counterfeit medications often misrepresent their origin, legitimacy, or efficacy, jeopardizing public health. These products may contain insufficient or no active ingredients, leading to treatment failure or adverse effects. Combatting counterfeit drugs is essential to ensure consumer safety and market growth.

Challenges in Underdeveloped Areas

Expanding the consumer healthcare market faces challenges in underdeveloped regions where inadequate healthcare infrastructure, weak economies, and limited awareness hinder the distribution of products and services. Lack of access to digital solutions and skepticism about new products further impede market growth in these areas.

Key Market Trends

Accelerated Use of Online Resources

The increased use of online resources in the consumer healthcare industry is a prominent trend. Online platforms provide health-related information, enabling self-medication with OTC medicines. Consumer healthcare companies are leveraging online platforms for marketing and sales, expanding e-commerce channels, and meeting the growing demand for health-related content and products.

Rising Inclination Towards Self-Medication

The trend toward self-medication is driving the demand for consumer healthcare products. Consumers are proactively addressing minor health issues with OTC medications, supplements, and health-related apps. This trend is influencing product development and increasing the demand for a range of healthcare solutions.

Segmental Insights

Type Segment

The market is divided into OTC Pharmaceuticals and Dietary Supplements. OTC pharmaceuticals dominate the market due to their safe and effective nature for treating common illnesses. However, Dietary Supplements, including vitamins and minerals, are projected to experience the highest growth rate as consumers seek personalized health solutions.

End User Segment

Retail is the largest segment, encompassing retail pharmacies and organized/unorganized retail stores. Online retail is expected to grow rapidly due to increasing internet penetration and awareness of online shopping benefits.

Regional Insights

North America leads the market, driven by major pharmaceutical companies and efficient distribution channels. Europe follows with growing demand for natural ingredients and preventive healthcare. The Asia Pacific region is also experiencing growth, particularly due to rising awareness and internet penetration.

Key Market Players

Pfizer Inc.
Teva Pharmaceutical Industries Limited
Johnson & Johnson
GlaxoSmithKline plc
Sanofi S.A.
Amway Corp.
Bayer AG
BASF SE
Abbott Laboratories
Boehringer Ingelheim International Gmbh

Report Scope:

In this report, the Global Consumer Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Consumer Healthcare Market, By Type:

OTC Pharmaceuticals
Dietary Supplements

Consumer Healthcare Market, By Application:

Retail
Online
Hospitals

Consumer Healthcare Market, By Region:

North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
Turkey
Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Consumer Healthcare Market.

Available Customizations:

Global Consumer Healthcare market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Consumer Healthcare Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (OTC Pharmaceuticals, Dietary Supplements)
- 5.2.2. By Application (Retail, Online, Hospitals)
- 5.2.3. By Region
- 5.2.4. By Company (2022)
5.3. Market Map

6. North America Consumer Healthcare Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Consumer Healthcare Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Consumer Healthcare Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Consumer Healthcare Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application

7. Europe Consumer Healthcare Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Consumer Healthcare Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. United Kingdom Consumer Healthcare Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. Italy Consumer Healthcare Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. France Consumer Healthcare Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Consumer Healthcare Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Asia-Pacific Consumer Healthcare Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Consumer Healthcare Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. India Consumer Healthcare Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Japan Consumer Healthcare Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. South Korea Consumer Healthcare Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Consumer Healthcare Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. South America Consumer Healthcare Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Consumer Healthcare Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. Argentina Consumer Healthcare Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. Colombia Consumer Healthcare Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. Middle East and Africa Consumer Healthcare Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Consumer Healthcare Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Saudi Arabia Consumer Healthcare Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. UAE Consumer Healthcare Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
- 15.5.1. Pfizer Inc.
- 15.5.2. Teva Pharmaceutical Industries Limited
- 15.5.3. Johnson & Johnson
- 15.5.4. GlaxoSmithKline plc
- 15.5.5. Sanofi S.A.
- 15.5.6. Amway Corp.
- 15.5.7. Bayer AG
- 15.5.8. BASF SE
- 15.5.9. Abbott Laboratories
- 15.5.10. Boehringer Ingelheim International Gmbh